4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-15-069481
Chief Financial Officer sold 3,000 shares at $11.33 ($33,990)
- Chief Financial Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Knudson Susan A. Chief Financial Officer | 2015-09-01 | Option exercise | +3,000 | $1.22 | $3,660 | 3,492 | D |
| Knudson Susan A. Chief Financial Officer | 2015-09-01 | Sale | −3,000 | $11.33 | $33,990 | 492 | D |
| Derivatives | |||||||
| Knudson Susan A. Chief Financial Officer | 2015-09-01 | Option exercise · Stock Option (Right to Buy) | −3,000 | 30,718 | D | ||
| Open-market sales · 3,000 sh · avg $11.33 · $33,990 | |||||||
Loading xslF345X03/doc4.xml…